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Background:Daptomycin forms oligomeric pores in bacterial cell membranes. Cardiolipin is a membrane lipid associated
with bacterial resistance to the antibiotic.
Results: Cardiolipin makes liposomes impervious to daptomycin permeabilization, and it confines daptomycin to the outer
membrane leaflet.
Conclusion: Preventing daptomycin from reaching the inner membrane leaflet inhibits pore formation.
Significance: Bacteria may become resistant to daptomycin by changing their membrane lipid composition.
Daptomycin is an acidic lipopeptide antibiotic that, in the
presence of calcium, forms oligomeric pores on membranes
containingphosphatidylglycerol. It is clinically used against var-
ious Gram-positive bacteria such as Staphylococcus aureus and
Enterococcus species. Genetic studies have indicated that an
increased content of cardiolipin in the bacterial membranemay
contribute to bacterial resistance against the drug. Here, we
used a liposome model to demonstrate that cardiolipin directly
inhibitsmembrane permeabilization by daptomycin.When car-
diolipin is added at molar fractions of 10 or 20% to membranes
containing phosphatidylglycerol, daptomycin no longer forms
pores or translocates to the inner membrane leaflet. Under the
same conditions, daptomycin continues to form oligomers;
however, these oligomers contain only close to four subunits,
which is approximately half asmany as observed onmembranes
without cardiolipin. The collective findings lead us to propose
that a daptomycin pore consists of two aligned tetramers in
opposite leaflets and that cardiolipin prevents the translocation
of tetramers to the inner leaflet, thereby forestalling the forma-
tion of complete, octameric pores. Our findings suggest a possi-
ble mechanism by which cardiolipin may mediate resistance to
daptomycin, and they provide new insights into the actionmode
of this important antibiotic.
Daptomycin is a lipopeptide antibiotic that consists of 13
amino acids, several of which are nonstandard ones. The 10
C-terminal amino acids form a ring that is closed by an ester
bond between a kynurenine residue and a threonine residue,
whereas a decanoyl residue is attached to the exocyclic N-ter-
minal tryptophan (Fig. 1). The antibacterial action mode of
daptomycin is not yet fully understood and may be multifac-
eted. Membrane permeabilization and interference with cell
division have been demonstrated, whereas inhibition of cell
wall synthesis remains somewhat contentious (1). Membrane
permeabilization can be observed in model liposomes and
involves the formation of an oligomeric and cation- and size-
selective pore. Oligomerization and pore formation require
phosphatidylglycerol (PG),2 which is abundant in bacterial cell
membranes but not in mammalian ones; this presumably con-
tributes to the selectivity of the drug for bacteria (2–5).
Since its approval for clinical use in 2003, daptomycin has
assumed amajor role in the treatment of infections with Gram-
positive pathogens. Although the overall resistance situation is
currently still favorable, resistant strains of Staphylococcus
aureus and Enterococcus species occur. Genomic analysis of
resistant strains indicate that resistancemay involve changes in
the lipid composition of the bacterial cell membrane. Such
changes include the reduced synthesis of PG (4) and the increased
conversion of PG to lysyl-phosphatidylglycerol (lysyl-PG (6)).
Because lysyl-PG is positively charged, it likely detracts from the
calcium-mediated membrane binding of daptomycin, which
would resemble its known inhibitory effect on cationic antimicro-
bial peptides.
Another set of mutations implicates cardiolipin. Mutations
that enhance cardiolipin synthase activity (7) were found in
resistant Enterococcus strains (8), although replacement of the
wild-type synthase with a mutant gene into a wild-type Entero-
coccus faecalis strain did not detectably change the susceptibil-
ity to daptomycin (9). Quantitative data on cardiolipin mem-
brane levels in daptomycin-resistant Enterococcus strains are
not available; therefore, whether or not changes in cardiolipin
content can increase the daptomycin resistance in vivo remains
to be elucidated. Here, we examined the question whether or
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(NSERC) and Canadian Institutes of Health Research (CHIR) (to S. D. T. and
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not cardiolipin can in principle affect the susceptibility ofmem-
branes to daptomycin. We found that cardiolipin may indeed
protect lipidmembranes frompermeabilization. The inhibitory
mechanism of cardiolipin is novel and surprising, and it pro-
vides further insight into the mechanism of daptomycin pore
formation.
EXPERIMENTAL PROCEDURES
Preparation of Liposomes (LUV) for Fluorescence Exper-
iments—Phospholipidswere obtained fromAvanti Polar Lipids
(Alabaster, AL) and used as received. For fluorescence experi-
ments, 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC)
and 1,2-dimyristoyl-sn-glycero-3-phospho-rac-(1-glycerol)
(DMPG) as well as tetraoleyl-cardiolipin (TOCL) were dis-
solved in chloroform:methanol 3:1, mixed at the molar ratios
indicated under “Results,” and dried down under nitrogen and
vacuum in a round bottom flask. The lipid filmwas dispersed in
100 mMNaCl buffered with 10 mMHepes (pH 7.4; Hepes-buff-
ered saline (HBS)), and the lipid suspension was extruded
10–15 times through 100-nm polycarbonate membranes with
a nitrogen-driven device (10). The liposomes were used in
fluorescence experiments at a final concentration of 250 M
total lipid. All experiments involving these liposomes were car-
ried out at 30 °C.
Preparation of Liposomes (LUV) for ITC Experiments—LUV
were prepared using the freeze-thaw and extrusion method as
described previously (11). Lipid films were prepared by mixing
appropriate volumes of pure DOPC, DOPG, and TOCL
(Avanti) from stock solutions in chloroform and evaporating
the solvent under a streamof nitrogen. The resulting filmswere
hydrated in HBS (10mMHepes, 100mMNaCl, 1 mMCaCl2, pH
7.4) to a final total lipid concentration of 5 mM.
Measurement ofMembrane Permeabilization with Pyranine-
loaded Liposomes—This procedure was carried out exactly as
described.3 Briefly, LUV for fluorescence experiments were
prepared as above, but with an internal pH of 6.0 and entrapped
pyranine (5 mM internal concentration). The liposomes were
diluted into Hepes (10 mM, pH 8.0)-buffered potassium chlo-
ride (100 mM) with 5 mM CaCl2 and supplemented with car-
bonyl cyanide m-chlorophenylhydrazone (CCCP), 5 nM), vali-
nomycin (0.5 M), and daptomycin (1 M) as indicated. After
incubation for 300 s, the samples were solubilized with Triton
X-100, and the fluorescence signal recorded thereafter was
used to normalize the entire data set.
Measurements of Perylene Excimer Fluorescence—Perylene-
daptomycin was prepared as described before (13). The com-
pound was added to LUV at 2 M. Calcium was added to 5 mM,
the samples were incubated for 5 min, and the fluorescence
emission were recorded with excitation at 430 nm.
Isothermal Calorimetry—Energetics of daptomycin binding
to model membranes was investigated by high sensitivity iso-
thermal titration calorimetry (MicroCal VP-ITC, GE Health-
care) as described in Ref. 11. Briefly, the sample cell (1.4 ml)
was filledwith 23Mdaptomycin prepared inHBS containing 1
mM calcium, and the reference cell was filled with identical
buffer. The 250-l syringe was loaded with 5 mM total lipid
LUV suspension. Daptomycin solutions and lipid suspensions
were degassed with stirring under vacuum for 20 min prior to
each titration. After system equilibration and a preliminary
1-l injection that was omitted from data analysis, 2.5-l ali-
quots were injected into the sample cell at 6-min intervals. Data
were collected by the MicroCal customized Origin software.
Baselines were normalized using Nitpic (14), and the results
were analyzed with the Origin “one binding site” model.
Langmuir Monolayers—The ability of daptomycin to pene-
trate lipid monolayers was examined using a Langmuir surface
balance and custom-built mini-trough from KSV-Nima (Biolin
Scientific, Espoo, Finland). The aqueous subphase was HBS
with 1 mM calcium, prepared with water purified through a
Milli-Q system (Millipore, Molsheim, France). Lipid solutions
were prepared by dissolving DOPC, DOPG, and TOCL in spec-
troscopy-grade chloroform to concentrations of 1 mg/ml.
The trough was filled with buffer, and the surface was cleaned
by aspirating. Small aliquots of lipid solution were applied to
the surface using aHamilton digital syringe (Reno, NV) until an
initial surface pressure of 20 mN/m was obtained. After allow-
ing 10 min for solvent evaporation and monolayer equilibra-
tion, 50 l of 1 mM daptomycin, prepared in identical buffer,
were injected into the stirred subphase through a side port to
avoid puncturing the monolayer. Daptomycin insertion into
the lipid monolayer was monitored over time and detected by
surface pressure increase at constant area. Each experiment
was performed at least in triplicate.
Determination of Daptomycin Oligomer Subunit Stoichiom-
etry by FRET—Nitrobenzoxadiazole-daptomycin (NBD-dapto-
mycin) was prepared as described in Ref. 15. Fluorescence
experiments and data analysis were performed exactly as
described previously (16), except that the lipid composition of
the liposomes was varied as indicated under “Results.”
Dithionite Quenching of NBD Fluorescence—For the experi-
ment shown in Fig. 8A, NBD-phosphatidylethanolamine
(NBD-PE) was obtained from Avanti and incorporated at 0.5%
mol/mol into LUV that otherwise consisted of equal fractions
of PC and PG. The liposomes were diluted into HBS supple-
mented with 25mM calcium.We found it necessary to raise the
3 T. Zhang, J. Muraih, B. MacCormick, and M. Palmer, M., submitted for
publication.
FIGURE 1. Structure of daptomycin. In NBD-daptomycin, the free amino
group of ornithine is modified with NBD. In perylene-daptomycin, the N-ter-
minally attacheddecanoyl residue is replacedbyperylene-butanoic acid (13).
Kynurenine has intrinsic fluorescence that can be used for FRET experiments
in conjunction with NBD (15).
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concentration this high from the usual value of 5 mM to induce
reaction between dithionite and liposomes containing PG; we
assume that calcium alleviates the electrostatic repulsion
between PG and dithionite. Daptomycin was added to 1 M
where indicated, and the samples were incubated for 5 min
before starting the fluorescence measurement (excitation
wavelength, 465 nm; emission wavelength, 530 nm). After 1
min, dithionite was added (final concentration 10 mM), and the
measurement was continued for5 min before the addition of
Triton X-100 to solubilize the liposomes.
The experiments illustrated in Fig. 8B were performed anal-
ogously, except that NBD-PE was omitted from the liposomes,
and daptomycinwas replacedwith amixture ofNBD-daptomy-
cin and native daptomycin (molar ratio 1:2; total final concen-
tration 1 M). The inclusion of native daptomycin served to
reduce NBD self-quenching.
RESULTS
Cardiolipin Inhibits Membrane Permeabilization by Dapto-
mycin—In a recent study, we showed that daptomycin forms
cation-selective pores of discrete size in liposomes composed of
PC and PG.3 As shown in Fig. 2, the addition of as little as 10%
cardiolipin completely inhibits this pore formation.
In previous studies, we have shown that membrane perme-
abilization by daptomycin occurs in several successive stages,
namely, monomer binding, oligomerization, and conversion of
the oligomer to a functional pore (11, 13, 15, 16). The following
experiments were carried out to determine which of these
stages is subject to inhibition by cardiolipin.
Binding and Oligomerization of Daptomycin on Membranes
Containing Cardiolipin—The binding of daptomycin to lipid
membranes correlates with a strong increase in the intrinsic
fluorescence of its kynurenine residue (17). Binding also
requires calcium, and the calcium concentration required to
induce the half-maximal extent of this fluorescence increase
([Ca]50) can be used to compare the affinity of daptomycin for
membranes differing in lipid composition. The [Ca]50 is 12
mM calcium with pure DMPC membranes, 0.2 mM with
DMPC/DMPGmembranes (1:1), and 2mMwithDMPC/TOCL
membranes. Thus, CL binds daptomycin more avidly than PC
but less avidly than PG. When CL is added to PC and PG, the
[Ca]50 remains close to 0.2 mM, which suggests that on such
membranes, daptomycin interacts with PG rather than CL
(data not shown).
Oligomerization of membrane-bound daptomycin can be
observed through excimer formation of a perylene-labeled dap-
tomycin derivative (13). Fig. 3A shows the fluorescence of per-
ylene-daptomycin onmembranes containing PC, PG, andCL in
various combinations. As reported in Ref. 13, the emission
spectrum observed on PC membranes is typical of perylene
monomers, indicating the absence of daptomycin oligomer for-
mation. On membranes consisting of PC and PG, monomer
intensity is reduced, and an overlapping, broad-based peak
excimer peak centered around 520 nm appears, indicating dap-
tomycin oligomer formation on these membranes.
The spectrum obtained with membranes containing PC and
CL, but no PG, closely resembles the one from pure PC lipo-
somes. Therefore, unlike PG, cardiolipin does not induce oligo-
merization of daptomycin. In contrast, membranes that con-
tain both PG and CL do induce formation of excimers, and
hence of daptomycin oligomers.
The extent of excimer formation can be compared using the
ratio of the emission at 560nm,wheremonomer fluorescence is
negligible, with that at 455 nm, wheremonomer fluorescence is
dominant. In Fig. 3B, this ratio is shown as a function of CL
molar fraction in the membrane. The extent of excimer forma-
tion drops noticeably from 0 to 10% CL and then increases
slightly again asmore CL is added. The potential significance of
this finding is discussed below.
Another method for observing daptomycin oligomerization
is the use of FRET between the kynurenine residue of the unla-
beled molecule and the fluorescent label NBD attached to the
ornithine side chain of a seconddaptomycinmolecule; theNBD
derivative retains full antibiotic activity (15). This method has
also been used to estimate the number of subunits in a single
daptomycin oligomer to 6–7 (16). In those previous experi-
ments, PC/PGmembranes where used, which allow the forma-
tion of functional pores (cf. Fig. 2A). Because the addition of CL
prevents pore formation, we considered that the oligomers that
form in the presence of CL might be structurally different and
FIGURE 2.Permeabilizationbydaptomycin of liposomes composedof PC
and PG (A) and PC, PG, and CL (B). The pH-sensitive fluorophore pyranine
was entrapped in liposomes. The increase in its fluorescence by the efflux of
protons was mediated by carbonyl cyanide m-chlorophenylhydrazone
(CCCP), in exchange for potassium influx mediated by valinomycin (green) or
daptomycin (red). Valinomycin is active on both membranes (but acts faster
on the ones containing CL), whereas daptomycin permeabilizes only the
membranes devoid of CL. The fluorescence intensity is scaled to that
observed after solubilization with Triton X-100, which equals 100 units.
FIGURE 3. Fluorescence of perylene-daptomycin on liposomes contain-
ingPCaloneor in various combinationswithPG (mole fraction30%)and
CL (mole fraction 10%). A, on PC membranes as well as on PC/CL mem-
branes, the spectrum is characteristic of the perylene monomer, indicating
that oligomer formation does not occur. PC/PG membranes with or without
10%CL show a diminishedmonomer peak and a broad, overlapping excimer
peak indicative of oligomer formation (13). The extent of excimer formation is
slightly lower in the sample with CL. B, the ratio of emissions at 560 and 445
nm can be used to compare the extent of excimer formation. This ratio is
shownhere as a function of the CLmole fraction (0–70%). PGwas constant at
30%, and the balance was made up by PC.
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contain a different number of subunits. Themethodused in this
experiment is fully explained in Ref. 16. Briefly, native dapto-
mycin and NBD-daptomycin are mixed in various proportions
and then applied to liposome membranes. Based on the
assumptions of 1) oligomer stability on the time scale of the
experiment, 2) random co-oligomerization, and 3) maximally
effective FRET between the subunits of the same oligomer, and
using corrections for FRET between molecules that are part of
separate oligomers, the number of subunits is calculated from
the residual observed donor fluorescence.
Fig. 4 shows that, indeed, the presence of cardiolipin changes
the subunit stoichiometry.With cardiolipin, therewere close to
four subunits, whereas without CL, the number was close to
seven, which is similar to the previously reported value (16).
These observations will be further discussed below.
Interaction of Daptomycin with Membranes Containing CL
by Surface Pressure and Isothermal Calorimetry (ITC)—Tobet-
ter understand the effect of CL on themembrane interaction of
daptomycin, we studied a similar model system with Langmuir
monolayers and with ITC. The insertion of daptomycin into
PC/PG lipid monolayers can be observed as an increase in sur-
face pressure. The addition of CL to this lipid mixture up to a
molar fraction of 10% substantially enhances this response (Fig.
5, A and B). This increase in the surface pressure differential
indicates a deeper and/or more stable insertion of daptomycin
molecules into monolayers containing CL. The surface pres-
sure differential decreases again when CL is added to molar
fractions of 20% or greater.
ITC was performed with LUV, which were added to a solu-
tion of daptomycin and calcium. Fig. 6 shows that, relative to
liposomes containing PC and PG only, the addition of CL up to
a molar fraction of 10% raised the enthalpy released by dapto-
mycin binding significantly. This increase in negative enthalpy
indicates a greater number of favorable molecular interac-
tions between daptomycin and the lipid molecules of the
membrane, which is consistent with the deeper membrane
insertion of daptomycin molecules inferred from the surface
pressure experiments.
The increase in negative enthalpy was accompanied by a
decrease in entropy, as obtained by fitting a single-site binding
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model to the raw data. At a molar fraction of 20% or more CL,
the changes to both the enthalpy and the entropy were partially
reversible.
It may be noted that the response to changes in CL molar
fraction was similar in three different assays, namely surface
pressure, ITC, and perylene excimer fluorescence, which sug-
gests that these assays reflect the same underlying effect of CL
on themembrane interaction of daptomycin. In all three assays,
themaximum signal was observed at a CLmole fraction of 10%,
whereas higher mole fractions caused a partial reversal. We
currently have no experimental basis on which to propose an
explanation for this reversal; it may be noted that molar frac-
tions of CL higher than 10% are not common in bacterial
membranes.
Cardiolipin Inhibits Membrane Translocation of Dapto-
mycin—One question that had not been addressed in our pre-
vious studies is how daptomycin distributes between the two
leaflets of the target membrane. The observation that cardioli-
pin both prevented pore formation and reduced the number of
oligomer subunits by approximately half suggested the possi-
bility that a functional pore might comprise subunits in both
leaflets, whereas the nonfunctional oligomers that form in the
presence of cardiolipin might be confined to the outer mem-
brane leaflet only (Fig. 7). This hypothesis was tested using the
fluorescence of NBD-daptomycin and its sensitivity to quench-
ing with dithionite.
NBD is instantly reduced, and its fluorescence is abolished,
by dithionite. Because dithionite is membrane-impermeant,
this reaction can be used in liposome models to detect the
accessibility of membrane-associated molecules from the out-
side (18). A potential complication that arises here, however, is
that daptomycin pores might allow dithionite to reach the lipo-
some interior and reduce NBD-daptomycin also bound to the
inner leaflet. Therefore, in a control experiment, a small
amount of NBD-PE was incorporated into PC/PG liposomes,
and its reduction by dithionite was monitored both with and
without daptomycin. In both cases, the extent of reduction is
close to 50%, which is consistent with a reduction ofNBD-PE in
the outer leaflet only (Fig. 8A). Thus, in keeping with the previ-
ously observed cation selectivity of the daptomycin pore,3
dithionite does not appreciably enter the liposomes on the time
scale of the experiment. Dithionite was also excluded by lipo-
somes containing CL in addition to PC and PG, with or without
daptomycin (data not shown).
Fig. 8B depicts the results obtained with NBD-daptomycin;
no NBD-PE was present in these experiments. When NBD-
daptomycin was bound to membranes containing PC, PG, and
either 10% or 20% CL, almost all NBD fluorescence was imme-
FIGURE 6. ITC experiments on daptomycin binding to PC/PG membranes with or without CL. A, representative raw traces. Each peak is caused by the
injection of 2.5 l of liposome suspension (see “Experimental Procedures” for details). CP, chlorophenylhydrazone. B, integrals (data points) and single-site
model fit curves for the traces shown in A. C, energies of interaction between daptomycin and liposomemembranes (mole fraction of CL as indicated, balance
of equal parts of PC and PG) obtained from a series of isothermal titrations (n 2–3 at each lipid composition). Each data point represents themeans S.D. of
3 or 4 repeated experiments.
FIGURE 7. Hypothetical model of daptomycin membrane insertion, pore formation, and pore structure. A, a daptomycin tetramer forms in the outer
membrane leaflet. B, its insertion into the head group layer is limited by the distension and creation of voids in the acyl chain layer; this is unfavorable in terms
of enthalpy and increases disorder (entropy). If CL is present, it provides extra bulk in the acyl chain layer, which stabilizes this situation and thus allows for
deeper penetration of daptomycin. C, if CL is not present, head group distension and voids in the acyl layermay alternatively cause the outer leaflet to cave in,
forming a half-toroidal structure. D, a tetramer as shown in Cmay flip to the other leaflet and then combine with a second tetramer in the outer leaflet, which
gives an octameric pore.
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diately quenched. In contrast, the extent of immediate quench-
ing was only about 50% in membranes that contained PC and
PGbut noCL. The remainder of the fluorescence decayedmore
slowly with a half-life of60–90 s, which is presumably due to
the redistribution of daptomycin from the inner to the outer
leaflet. These findings support the notion that daptomycin is
able to distribute symmetrically and reversibly between both
membrane leaflets in PC/PG membranes, but unable to trans-
locate across membranes containing 10 or 20% CL.
DISCUSSION
In this study, we have shown that cardiolipin inhibits the
pore-forming activity of daptomycin in a liposomemodel. This
study was prompted by genetic studies on daptomycin resis-
tance, which suggest that bacteria may become more resistant
to daptomycin by increasing the content of cardiolipin in their
cell membranes. We found that inclusion of 10% CL in model
membranes was sufficient to effectively suppress membrane
translocation and pore formation in liposomes. This fractional
amount of CL is at the upper end of the range reported for
bacterial cell membranes (19–21), which suggests that this
mechanism may be relevant for bacterial resistance to dapto-
mycin. Formation of daptomycin pores in bacterial cell mem-
branes, as detected by membrane depolarization, is well docu-
mented (22–24). It seems possible that an increased cardiolipin
content would inhibit pore formation in vivo; however, this has
yet to be experimentally examined. Daptomycinmay also dam-
age bacteria by more than one mechanism. If so, inhibition of
pore formation may not suffice to prevent bactericidal action,
and additional resistance mechanisms would then be required
to counter the other antibacterial action modes of the drug.
Whether or not the effect of CL observed in vitro has a role in
bacterial resistance, the findings of our study do provide signif-
icant new insight into the mechanism of daptomycin action.
Firstly, they show that oligomers can form in the outer leaflet
alone. However, these oligomers do not form functional pores,
and they do not reach the full number of subunits; instead, they
contain only four subunits. Pore formation correlates with dap-
tomycin reaching the inner membrane leaflet, and with an
increase in the apparent subunit stoichiometry to 6–7.
To account for the collective findings, we propose a working
model of pore formation that comprises the following steps (cf.
Fig. 7): 1) calcium-mediated binding ofmonomeric daptomycin
to PG in the outer leaflet of the target membrane; 2) formation
of a tetramer from four bound monomers (this step occurs
in the outer leaflet and is preserved in membranes that contain
cardiolipin); 3) translocation of tetramers from the outer leaflet
to the inner leaflet (this step is disrupted on membranes con-
taining CL); and 4) alignment of two tetramers in the opposite
leaflets to form an octameric functional pore.
In such an octamer, half of the subunits are located in the
outer leaflet and hence subject to reduction by dithionite right
away. The observation that the remainder of the NBD fluores-
cence is subject to protracted but ultimately complete reduc-
tion indicates that the translocation from the outer to the inner
leaflet is reversible. The reverse translocation might conceiv-
ably involve the dissociation of octamers into tetramers. How-
ever, we could find no evidence of such a dissociation in pre-
liminary experiments, and we therefore favor the view that
translocation comes about through the trading of places
between individual subunits within an intact octamer.
Although this model accounts for most of the available evi-
dence without contortions, the postulated octamer obviously is
at odds with the subunit stoichiometry (n) of 6–7 that was
experimentally obtainedwith PC/PGmembranes here and ear-
lier (16). Two effectsmight account for this discrepancy. Firstly,
it is possible that not all tetramers assemble into octamers. In
that case, the experimentally determined n would reflect an
average of tetramers and octamers, weighted for abundance.
However, because we could not detect dissociation of octamers
into tetramers, it seems likely that the number of free tetramers
is low at equilibrium.
Secondly, as was pointed out in our previous study (16), the
value ofn obtained fromFRET experimentsmay underestimate
the true value. The efficiency of FRET is limited by the Förster
distance, whichwas estimated to 2.7 nm for the couple of donor
and acceptor labels used here (kynurenine in unlabeled dapto-
mycin and NBD-daptomycin, respectively). The distance
between subunits that belong to the same oligomer, yet reside
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FIGURE 8.Distribution of daptomycin across inner and outer leaflets, examinedwith NBD fluorescence quenching using dithionite. A, control (dithio-
nite (10mM)) reduces only 50%ofNBD-PE (0.5% in PC/PGmembranes), both in the absence and in thepresenceof daptomycin. Therefore, dithionite continues
to be excluded frommembranes in the presence of daptomycin pores. A. U., absorbance units. B, in PC/PGmembranes containing 10 or 20% CL, most of the
NBD-daptomycin (NBD-dap.) is reducedbydithionite instantly, indicating that it is confined to theouter leaflet. In contrast, in PC/PGmembranes containingno
CL, immediate reduction affects only 50% of NBD-daptomycin, whereas the remainder is reduced at a slower pace, presumably rate-limited by redistribution
from the inner to the outer leaflet.
Cardiolipin Inhibits Daptomycin Pore Formation
APRIL 25, 2014•VOLUME 289•NUMBER 17 JOURNAL OF BIOLOGICAL CHEMISTRY 11589
 by guest on N
ovem
ber 28, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
in opposite membrane leaflets, might approach or even exceed
this value, which would significantly diminish FRET. Because
our analysis assumes FRET to be maximally effective between
any two positions within the same oligomer (16), a less than
maximal FRET efficiency will cause the calculated value of n to
underestimate the true value. Based on the currently available
evidence, we consider this the most likely explanation.
If we assume the above model to be correct, the question
arises exactly how cardiolipin may inhibit membrane translo-
cation of daptomycin tetramers. This inhibitory effect was
accompanied by several other changes. The slight drop of per-
ylene excimer fluorescence (Fig. 2B) may correspond to the
fraction of excimers that form between perylene-daptomycin
molecules in two opposite tetramers that are part of the same
octamer, whereas the remaining excimer fluorescence arises
from proximity within single tetramers. In liposomes, CL
effected a notable increase in daptomycin binding enthalpy,
which suggests an increase in the number of favorable molecu-
lar contacts (25). In lipid monolayers, CL caused a greater
increase in surface pressure in response to a given quantity of
daptomycin. This suggests a deeper insertion of daptomycin
into membranes containing moderate amounts of CL, which
should increase the number of molecular contacts between
daptomycin and the surrounding lipids, and therefore agrees
with the findings from the ITC experiments.
A similar inhibitory effect of CL on membrane pore forma-
tion has previously been observed with the antimicrobial pep-
tide magainin, and together with related findings has been
interpreted in terms of lipid curvature strain (26). According to
this explanation, the peptide claims space in the head group
layer of the membrane. CL and other “cone-shaped” lipid spe-
cies that provide more bulk in the hydrophobic acyl chain layer
than in the head group layer accommodate the peptide,
whereas lipids with larger head groups compete with it for
space, promoting distension and bending of the head group
layer, which leads to the formation of a toroidal pore.
The mechanism proposed for magainin may also underlie
the effect ofCLondaptomycin (Fig. 7). Such amodelmight lead
one to expect that, because of the greater competition for space
in the head group layer of monolayers without CL, daptomycin
insertion into such monolayers should raise the surface pres-
sure to a greater extent than without CL, which is the opposite
of what we observed (Fig. 5). Possibly, the unstable situation
illustrated in Fig. 7B may relax by transitioning either toward
the toroidal defect (Fig. 7, C and D) or toward a less deeply
inserted configuration, inwhich the bulk of the peptide remains
outside of the lipidmembrane and does not add lateral pressure
to it (Fig. 7A). In any event, an improved accommodation of
daptomycin within CL-containing membranes would agree
with the increase in negative enthalpy reported here. In this
context, it is worth noting that CL is believed to be enriched in
localized domains in bacterial cell membranes (27). This might
account for the inhomogeneous distribution of daptomycin on
cell surfaces (28); the correlation has, however, not been
established.
A tighter interaction between daptomycin and membrane
lipids might also account for the decrease in entropy that was
observed concomitantly with increases in negative enthalpy.
However, one should keep inmind that the entropy values were
obtained through the use of a single-site binding model, and
although this model is able to numerically fit the ITC titration
curves ratherwell, wemust not forget that daptomycin not only
binds as a monomer but subsequently also forms oligomers, so
that any model that assumes a one-step interaction can only be
considered an approximation. Caution is therefore required
with respect to interpreting the calculated entropy.
In sum, we have obtained evidence that supports a novel
structural model of the daptomycin pore and suggests a possi-
ble mechanism of bacterial resistance to daptomycin.We pres-
ently have no way to further corroborate this hypothetical
model. Nevertheless, it is interesting to note that many cation
channels and pores have tetradic symmetry. Intriguingly, with
the Pseudomonas lipopeptide tolaasin I, whose structure is not
closely related to daptomycin, the very same kind of octameric
symmetry spanning both leaflets has been obtained from in
silico studies (12). We therefore feel that this structural model
deserves consideration in future studies.
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